PL1761514T3 - Nowe tetracykliczne pochodne tetrahydrofuranu - Google Patents
Nowe tetracykliczne pochodne tetrahydrofuranuInfo
- Publication number
- PL1761514T3 PL1761514T3 PL05752829T PL05752829T PL1761514T3 PL 1761514 T3 PL1761514 T3 PL 1761514T3 PL 05752829 T PL05752829 T PL 05752829T PL 05752829 T PL05752829 T PL 05752829T PL 1761514 T3 PL1761514 T3 PL 1761514T3
- Authority
- PL
- Poland
- Prior art keywords
- tetrahydrofuran derivatives
- novel tetracyclic
- tetracyclic tetrahydrofuran
- novel
- derivatives
- Prior art date
Links
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical class C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2004051105 | 2004-06-14 | ||
| PCT/EP2005/052706 WO2005121113A1 (en) | 2004-06-14 | 2005-06-13 | Novel tetracyclic tetrahydrofuran derivatives |
| EP05752829A EP1761514B1 (en) | 2004-06-14 | 2005-06-13 | Novel tetracyclic tetrahydrofuran derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1761514T3 true PL1761514T3 (pl) | 2009-01-30 |
Family
ID=34957878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05752829T PL1761514T3 (pl) | 2004-06-14 | 2005-06-13 | Nowe tetracykliczne pochodne tetrahydrofuranu |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070197525A1 (pl) |
| EP (1) | EP1761514B1 (pl) |
| JP (1) | JP2008502649A (pl) |
| CN (1) | CN1968942B (pl) |
| AR (1) | AR049512A1 (pl) |
| AT (1) | ATE402932T1 (pl) |
| AU (1) | AU2005251948A1 (pl) |
| CA (1) | CA2567847A1 (pl) |
| DE (1) | DE602005008596D1 (pl) |
| DK (1) | DK1761514T3 (pl) |
| ES (1) | ES2311228T3 (pl) |
| PL (1) | PL1761514T3 (pl) |
| PT (1) | PT1761514E (pl) |
| TW (1) | TW200612899A (pl) |
| WO (1) | WO2005121113A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ562008A (en) * | 2005-05-26 | 2010-03-26 | Janssen Pharmaceutica Nv | Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament |
| EP2727585A1 (en) | 2006-05-16 | 2014-05-07 | Takeda Pharmaceutical Company Limited | In-vivo screening method |
| EP2216023A4 (en) | 2007-11-15 | 2013-03-13 | Takeda Pharmaceutical | CONDENSED PYRIDINE DERIVATIVE AND ITS USE |
| CA3014688A1 (en) | 2008-12-19 | 2010-07-15 | Supernus Pharmaceuticals, Inc. | Use of molindone for the treatment of aggression, irritability, or impulsivity |
| US8748472B2 (en) | 2010-03-31 | 2014-06-10 | Supernus Pharmaceuticals, Inc. | Stabilized formulations of CNS compounds |
| CN103874697A (zh) * | 2011-08-03 | 2014-06-18 | 协和发酵麒麟株式会社 | 二苯并氧杂*衍生物 |
| WO2013189920A1 (en) | 2012-06-19 | 2013-12-27 | Ucb Pharma S.A. | New compound based on cinchona alkaloïds for use in asymmetric michael addition |
| JPWO2019131902A1 (ja) | 2017-12-27 | 2020-12-10 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3507920A (en) * | 1964-10-16 | 1970-04-21 | Sterling Drug Inc | Hydroxydibenzo(a,d)cyclohepten-5-ones and esters and ethers thereof |
| US3562331A (en) * | 1964-10-16 | 1971-02-09 | Sterling Drug Inc | Amino-lower-alkoxy-dibenzo(a,d)cycloheptene-5-carbinols |
| US3565956A (en) * | 1964-10-16 | 1971-02-23 | Sterling Drug Inc | Amino-lower-alkoxy-5-alkylidene-dibenzo(a,d)cycloheptenes |
| US3350405A (en) * | 1964-10-16 | 1967-10-31 | Sterling Drug Inc | Amino-lower-alkoxy-dibenzo [a, d] cyclohepten-5-ones and 10, 11-dihydro derivatives thereof |
| US3812119A (en) * | 1969-11-21 | 1974-05-21 | Ciba Geigy Corp | Dibenzocycloheptenes |
| DE69720709T2 (de) * | 1996-04-12 | 2004-03-11 | Janssen Pharmaceutica N.V. | Substituierte tetracyclische tetrahydrofuranderivate |
| UA52778C2 (uk) * | 1997-10-10 | 2003-01-15 | Янссен Фармацевтика Н.В. | Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі |
| ATE294168T1 (de) * | 2001-12-07 | 2005-05-15 | Janssen Pharmaceutica Nv | Herstellung von trans-kondensierte 3,3a,8,12b- tetrahydro-2h-dibenzo(3,4:6,7)cyclohepta(1,2- b)furan derivaten |
-
2005
- 2005-06-13 WO PCT/EP2005/052706 patent/WO2005121113A1/en not_active Ceased
- 2005-06-13 TW TW094119426A patent/TW200612899A/zh unknown
- 2005-06-13 DK DK05752829T patent/DK1761514T3/da active
- 2005-06-13 AT AT05752829T patent/ATE402932T1/de active
- 2005-06-13 EP EP05752829A patent/EP1761514B1/en not_active Expired - Lifetime
- 2005-06-13 CN CN2005800194190A patent/CN1968942B/zh not_active Expired - Fee Related
- 2005-06-13 AR ARP050102402A patent/AR049512A1/es not_active Application Discontinuation
- 2005-06-13 US US11/570,433 patent/US20070197525A1/en not_active Abandoned
- 2005-06-13 JP JP2007515942A patent/JP2008502649A/ja active Pending
- 2005-06-13 CA CA002567847A patent/CA2567847A1/en not_active Abandoned
- 2005-06-13 PL PL05752829T patent/PL1761514T3/pl unknown
- 2005-06-13 ES ES05752829T patent/ES2311228T3/es not_active Expired - Lifetime
- 2005-06-13 PT PT05752829T patent/PT1761514E/pt unknown
- 2005-06-13 DE DE602005008596T patent/DE602005008596D1/de not_active Expired - Lifetime
- 2005-06-13 AU AU2005251948A patent/AU2005251948A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AR049512A1 (es) | 2006-08-09 |
| DK1761514T3 (da) | 2008-12-01 |
| ATE402932T1 (de) | 2008-08-15 |
| EP1761514B1 (en) | 2008-07-30 |
| CA2567847A1 (en) | 2005-12-22 |
| AU2005251948A1 (en) | 2005-12-22 |
| DE602005008596D1 (de) | 2008-09-11 |
| PT1761514E (pt) | 2008-10-28 |
| CN1968942B (zh) | 2011-06-15 |
| US20070197525A1 (en) | 2007-08-23 |
| WO2005121113A1 (en) | 2005-12-22 |
| ES2311228T3 (es) | 2009-02-01 |
| EP1761514A1 (en) | 2007-03-14 |
| JP2008502649A (ja) | 2008-01-31 |
| TW200612899A (en) | 2006-05-01 |
| CN1968942A (zh) | 2007-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL180962A0 (en) | Novel thiophene derivatives | |
| TWI369356B (en) | Tetrahydropyridoindole derivatives | |
| IL180481A0 (en) | Aryl-pyridine derivatives | |
| ZA200609595B (en) | Novel CIS-Imidazolines | |
| IL180331A0 (en) | 3-carbamoyl - 2 - pyridone derivative | |
| ZA200610102B (en) | Pyrrazolo-pyrimidine derivatives | |
| IL183140A0 (en) | Substituted benzoquinolizine derivatives | |
| ZA200703172B (en) | Imidazo-benzodiazepine derivatives | |
| ZA200705027B (en) | Phenyl-piperazin methanone derivatives | |
| IL183142A0 (en) | New pyridothienopyrimidine derivatives | |
| AP2074A (en) | New 4-benzylidene-piperidin derivatives | |
| IL183141A0 (en) | New pyridothienopyrimidine derivatives | |
| GB0414272D0 (en) | OsK1 derivatives | |
| IL177204A0 (en) | Novel 4-benzimidazol -2-ylpyridazin -3- one derivatives | |
| PT1761514E (pt) | Novos derivados de tetra-hidrofurano tetracíclicos | |
| IL179444A0 (en) | 4-phenyl-pyrimidine-2-carbonitrile derivatives | |
| TWI346109B (en) | 4-amino-5-cyanopyrimidine derivatives | |
| IL182001A0 (en) | 2-acylaminothiazole derivatives | |
| ZA200703442B (en) | Proline derivatives | |
| HUP0402371A2 (en) | Novel 125-i-labeled amino-quinoline derivatives | |
| GB0418566D0 (en) | Tropane derivatives | |
| GB0405905D0 (en) | Azaquinazoline derivatives | |
| GB0422397D0 (en) | 3-Cyano-Quinoline derivatives | |
| GB0411078D0 (en) | Bicyclic derivatives |